The role of Arg78 in the metabotropic glutamate receptor mGlu1 for agonist binding and selectivity

被引:27
|
作者
Jensen, AA
Sheppard, PO
O'Hara, PJ
Krogsgaard-Larsen, P
Bräuner-Osborne, H
机构
[1] Royal Danish Sch Pharm, Dept Med Chem, Neurosci Pharmabiotec Res Ctr, DK-2100 Copenhagen, Denmark
[2] Zymogenet Inc, Seattle, WA 98105 USA
关键词
mGlu(1) receptor; Arg(78); agonist binding; glutamic acid; quisqualic acid; mutagenesis;
D O I
10.1016/S0014-2999(00)00283-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabotropic glutamate receptors belong to family C of the G-protein coupled receptor superfamily. These receptors all possess large extracellular amino terminal domains, where agonist binding takes place. We have previously constructed a molecular model of the amino terminal domain of the mGlu(1) receptor based on a weak amino acid sequence similarity with a family of bacterial periplasmic binding proteins (PBPs). The residues Ser(165) and Thr(188) were demonstrated to be involved in agonist binding to the receptor. Here, we report that mutation of Arg(78) in the mGlu(1b) receptor to leucine or glutamate completely knocks out [H-3]quisqualic acid binding to the receptor. The constructed mutants, R78L and R78E, have also been characterized in a inositol phosphate assay. Here, the potency of (S)-glutamic acid and (S)-quisqualic acid was reduced 1000- and 100-fold, respectively, on R78L compared to the wild type (WT) receptor. (S)-Quisqualic acid was as potent on mutant R78E as it was on R78L, whereas (S)-glutamic acid was unable to activate R78E significantly at concentrations up to 10 mM. in conclusion, Arg(78) appears to be essential for agonist binding to the mGlu(1) receptor, most likely, through the formation of an ionic bond between its positively charged side chain and the distal acid group of the agonists. Furthermore, the different impact of the two mutations on (S)-glutamic acid and (S)-quisqualic acid potencies strongly indicates that while Arg(78) appears to be a common site of interaction for the agonists, the Group I subtype selectivity of (S)-quisqualic acid is probably determined by other residues in the amino terminal domain. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [41] Role of the Metabotropic mGlu5 Glutamate Receptor in the Initiation of Puberty and Reproduction in Female Mice
    Inta, Ioana
    De Angelis, Roberto
    Domonkos, Emese
    Lankisch, Katja
    Boehm, Ulrich
    Gass, Peter
    Bettendorf, Markus
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 414 - 414
  • [42] Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
    Notartomaso, Serena
    Zappulla, Cristina
    Biagioni, Francesca
    Cannella, Milena
    Bucci, Domenico
    Mascio, Giada
    Scarselli, Pamela
    Fazio, Francesco
    Weisz, Filippo
    Lionetto, Luana
    Simmaco, Maurizio
    Gradini, Roberto
    Battaglia, Giuseppe
    Signore, Michele
    Puliti, Aldamaria
    Nicoletti, Ferdinando
    MOLECULAR BRAIN, 2013, 6
  • [43] Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1
    Suzuki, Y
    Moriyoshi, E
    Tsuchiya, D
    Jingami, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) : 35526 - 35534
  • [44] Location-Dependent Signaling of the Group 1 Metabotropic Glutamate Receptor mGlu5
    Jong, Yuh-Jiin I.
    Sergin, Ismail
    Purgert, Carolyn A.
    O'Malley, Karen L.
    MOLECULAR PHARMACOLOGY, 2014, 86 (06) : 774 - 785
  • [45] Molecular modeling and mutagenesis of the ligand-binding pocket of the mGlu3 subtype of metabotropic glutamate receptor
    Yao, Y
    Pattabiraman, N
    Michne, WF
    Huang, XP
    Hampson, DR
    JOURNAL OF NEUROCHEMISTRY, 2003, 86 (04) : 947 - 957
  • [46] Activation of metabotropic glutamate receptor 1 dimers requires glutamate binding in both subunits
    Kammermeier, PJ
    Yun, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (02): : 502 - 508
  • [47] Role of metabotropic glutamate receptor 1 in cell survival and proliferation
    Pshenichkin, S.
    Grajkowska, E.
    Takoudjou, G. R.
    Emery, A. C.
    Wroblewski, J. T.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 619 - 619
  • [48] Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites
    Selvam, Chelliah
    Lemasson, Isabelle A.
    Brabet, Isabelle
    Oueslati, Nadia
    Karaman, Berin
    Cabaye, Alexandre
    Tora, Amelie S.
    Commare, Bruno
    Courtiol, Tiphanie
    Cesarini, Sara
    McCort-Tranchepain, Isabelle
    Rigault, Delphine
    Mony, Laetitia
    Bessiron, Thomas
    McLean, Heather
    Leroux, Frederic R.
    Colobert, Francoise
    Daniel, Herve
    Goupil-Lamy, Anne
    Bertrand, Hugues-Olivier
    Goudet, Cyril
    Pin, Jean-Philippe
    Acher, Francine C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 1969 - 1989
  • [49] The role of the extreme amino terminal domain of group III metabotropic glutamate receptors in agonist binding
    Rosemond, E
    Hampson, DR
    NEUROPHARMACOLOGY, 2002, 43 (02) : 306 - 306
  • [50] CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding
    Litschig, S
    Gasparini, F
    Rueegg, D
    Stoehr, N
    Flor, PJ
    Vranesic, I
    Prezeau, L
    Pin, JP
    Thomsen, C
    Kuhn, R
    MOLECULAR PHARMACOLOGY, 1999, 55 (03) : 453 - 461